SynthesisScientific reports2016

The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis.

Sa Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.